YATEP - The Impact of Horse Assisted Therapy (HAT) on Treatment Outcomes

Sponsor
Oslo University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT01795755
Collaborator
Swedish-Norwegian Foundation for Equine Research (Other), The Research Council of Norway (Other)
50
1
2
47
1.1

Study Details

Study Description

Brief Summary

The objective of the study is to assess the impact of horse assisted therapy (HAT) on:
  • Addiction treatment outcomes (its effectiveness as an alternative therapy)

  • Addiction treatment dropout & addiction relapse (its efficacy in preventing dropout).

Hypothesis: HAT will correlate with:
  • beneficial treatment outcomes of depression, anxiety, aggression

  • with improved self esteem & motivation

  • lower treatment dropout & addiction relapse.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Mentalization based inpatient treatment.
  • Behavioral: Horse assisted Therapy (HAT)
N/A

Detailed Description

Background Inclusion of horses in therapeutic settings is a scientific issue with significant social and health implications in Norway. Challenges include increasing provision of horse assisted therapy of variable quality to vulnerable population groups with little substantiating evidence of associated benefit(s) due to lack of research, design issues, mainstream clinicians'/scientists' scepticism of "alternative therapy" and associated difficulties in attracting top researchers and funding. Extensive review of literature found a growing volume of studies but as indicated in the most recent systematic review, there are few studies with adequate research design.

Oslo University Hospital's Dept of Addiction Treatment - Youth (AUA) presents a unique research/evaluation potential to study HAT. It will treat approximately 100 patients per year aged 16 to 26 years with a primary diagnosis of addiction. Horse assisted therapy (using AUA's residential herd) is an integral part of the addiction therapeutic program. Furthermore, AUA's strong emphasis on research and its Youth Addiction Treatment Evaluation Project (YATEP) data base will provide an evidence base needed for sound study in an emerging area of science and psychotherapy.

Patient drop out from addiction therapy is high, often exceeding 50% (Stark 1992). Many AUA patients claim that they remain in treatment because of the horses.

The study is a randomised controlled trial of in-patients undergoing treatment. The Participant Group has treatment as usual plus HAT; the Control Group treatment as usual.

Participant and control groups are drawn from AUA patients (aged 16 to 26 years of age with a primary diagnosis of addiction International Classification of Diseases (ICD F10-F19), admitted between 2013 and 2014 to AUA's in-patient unit and who have consented to participate in research.

HAT is a structured program of 12 X 90 minute therapeutic sessions with horses, including horse care, ground and mounted work, conducted by two clinically qualified therapists who are also Level I Riding Instructors.

Study Design

Study Type:
Interventional
Actual Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Impact of Horse Assisted Therapy (HAT) on Treatment Outcomes
Actual Study Start Date :
Jan 1, 2013
Actual Primary Completion Date :
Jun 1, 2016
Actual Study Completion Date :
Dec 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Treat as usual + Horse assisted therapy ( HAT)

Treatment as usual means mentalization based inpatient treatment. Horse assisted therapy(HAT) is a structured program of 12 X 90 minute sessions (horse care, ground and mounted work) conducted by two clinically qualified therapists.

Behavioral: Mentalization based inpatient treatment.
1-3 month of inpatient treatment

Behavioral: Horse assisted Therapy (HAT)
A structured program of 12 X 90 minute HAT sessions (horse care, ground and mounted work) conducted by two clinically qualified therapists who are also Level I Riding Instructors.

Active Comparator: Treatment as usual

Treatment as usual means mentalization based inpatient treatment.

Behavioral: Mentalization based inpatient treatment.
1-3 month of inpatient treatment

Outcome Measures

Primary Outcome Measures

  1. Lower treatment dropout [Within treatment period of upto 3 months]

    Reason for treatment exit, including drop out, is obtained from data recorded in the Department's YATEP data base.

Secondary Outcome Measures

  1. Lower emotional distress (composite measure) [Within the treatment period of upto 3 months]

    The measure tests whether depression, anxiety and depression improve with horse assisted therapy (as claimed in non-scientific/popular horse literature). Measurements are taken using Hopkins Symptom Check List (HSCL-25) and Severity Indices of Personality Problems (SIPP-118) from data recorded in the Department's YATEP data base.

  2. Improved self-esteem [Winthin the treatment period of upto 3 months]

    The measure tests whether self-esteem improves with horse assisted therapy (as claimed in non-scientific/popular horse literature). Improvement will be measured using the Rosenberg Self Esteem Scale from data recorded in the Department's YATEP data base.

Eligibility Criteria

Criteria

Ages Eligible for Study:
16 Years to 26 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Primary diagnosis of addictionInternational Classification of Diseases ICD F10-F19, admitted in 2011-2014 for treatment at AUA's in-patient unit
Exclusion Criteria:
  • Ongoing psychoses

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of addiction treatment - youth Oslo Norway 0514

Sponsors and Collaborators

  • Oslo University Hospital
  • Swedish-Norwegian Foundation for Equine Research
  • The Research Council of Norway

Investigators

  • Study Chair: Espen KA Arnevik, PhD, Oslo University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Espen Walderhaug, Principal Investigator, Oslo University Hospital
ClinicalTrials.gov Identifier:
NCT01795755
Other Study ID Numbers:
  • HAT-11-1
First Posted:
Feb 21, 2013
Last Update Posted:
Oct 8, 2020
Last Verified:
Oct 1, 2020
Keywords provided by Espen Walderhaug, Principal Investigator, Oslo University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 8, 2020